Patients from 105+ countries have trusted us
Join hundreds of happy patients who choose the right treatment and care.
Get A QuoteAcute Lymphocytic Leukemia Treatments in India
Acute Lymphocytic Leukemia
- Days In Hospital 30 days
- Outside Hospital Stay 60 days
- Success Rate %
Minimum Cost
$ 15000
Maximum Cost.
$ 35000
Most Asked Procedures
Overview of Acute Lymphocytic Leukemia in India
One kind of cancer of the blood and bone marrow, which is the spongy tissue inside bones where blood cells are produced, is called acute lymphocytic leukaemia (ALL).
The term "acute" in acute lymphocytic leukaemia refers to the disease's quick progression and production of immature blood cells as opposed to mature ones. The white blood cells known as lymphocytes that ALL affects are referred to as "lymphocytic" in acute lymphocytic leukaemia. Acute lymphoblastic leukaemia is another name for acute lymphocytic leukaemia.
The most prevalent cancer in children is acute lymphocytic leukaemia, which has a fair chance of being cured with treatment. Adults can also develop acute lymphocytic leukaemia; however, there is a much lower probability of recovery.
What is Acute Lymphocytic Leukaemia (ALL)?
A form of blood cancer called acute lymphocytic leukaemia (ALL), sometimes referred to as acute lymphoblastic leukaemia, is brought on by the immature development of lymphocytes, a type of white blood cell. The bone marrow, a soft area of the bones where blood cells are produced, is where ALL develops. Although it can strike anyone at any age, children are more frequently affected with acute lymphocytic leukaemia.
The term "acute" indicates that the illness has advanced quickly and may be lethal in a few months. In ALL, the term "lymphocytic" refers to the immature white blood cells known as lymphoblasts. In certain instances, ALL may also spread to the brain, testicles, liver, spleen, spinal cord, and lymph nodes.
Types of Acute Lymphocytic Leukemia:
There are several forms and subtypes of acute lymphoblastic leukaemia. Physicians determine this by examining the characteristics and structure of leukaemia cells. and whether the B or T cells are impacted. Your doctor can determine what kind of treatment you require by knowing the type.
Among the varieties of ALL are:
B cell acute lymphoblastic leukaemia (B cell ALL)
The most prevalent form of ALL in adults is this one. It has an impact on B cell lymphocytes. This kind accounts for about 75 out of every 100 cases of ALL.
Precursor B cell ALL is the most prevalent subgroup within B cell ALL. Your physician may discuss this with you.
T cell acute lymphoblastic leukaemia (T cell ALL)
Another name for it would be pre (precursor) T cell ALL. This is more prevalent in men and is more likely to impact young adults. This type accounts for about 25 out of every 100 individuals with ALL (about 25%).
The type of T cell ALL you have may be discussed with your physician.
Philadelphia positive ALL
A specific alteration in the leukaemia cells is known as Philadelphia positive leukaemia.
Philadelphia positive ALL occurs when a gene on chromosome 9 called ABL1 splits off and attaches itself to a gene on chromosome 22 called BCR. Tyrosine kinase is produced in excess by the cell as a result of the production of a novel gene termed BCR-ABL1. This protein promotes the growth and proliferation of leukaemia cells.
Older adults are more likely to have Philadelphia-positive ALL. It is estimated by researchers that between 20 and 30 percent of individuals with ALL are Philadelphia positive. Imatinib is a targeted cancer medication used by physicians to treat Philadelphia-positive ALL.
Procedure:
Treatment for acute lymphocytic leukaemia typically consists of the following phases:
Induction therapy
Restoring normal blood cell production and eliminating the majority of leukaemia cells in the bone marrow and blood are the goals of the initial stage of treatment.
Consolidation therapy
This stage of treatment, also known as post-remission therapy, aims to eradicate any leukaemia that may still be present in the body.
Maintenance therapy
Leukaemia cells are stopped from proliferating during the third stage of treatment. In this stage, therapies are typically administered over an extended length of time, frequently years, at substantially lower doses.
Preventive treatment to the spinal cord
In order to eradicate leukaemia cells in the central nervous system, patients with acute lymphocytic leukaemia may undergo extra treatment at each stage of treatment. Chemotherapy medications are frequently administered straight into the fluid covering the spinal cord during this kind of treatment.
Treatment for acute lymphocytic leukaemia can take two to three years, depending on your circumstances.
Among the possible treatments are:
Chemotherapy
For children and adults with acute lymphocytic leukaemia, chemotherapy is commonly used as an induction therapy. Chemotherapy uses chemicals to destroy cancer cells. Additionally, chemotherapy medications might be administered during the maintenance and consolidation stages.
Targeted therapy
Treatments with targeted drugs concentrate on particular anomalies found in cancer cells. Targeted medication therapies can kill cancer cells by preventing these anomalies. To determine whether targeted therapy is beneficial for you, your leukaemia cells will be examined. For induction therapy, consolidation therapy, or maintenance therapy, targeted therapy can be administered either by itself or in conjunction with chemotherapy.
Radiation therapy
High-powered beams like protons or X-rays are used in radiation therapy to destroy cancer cells. Your doctor can suggest radiation therapy if the cancer cells have progressed to the central nervous system.
Bone marrow transplant
In the event of a relapse, a bone marrow transplant—also referred to as a stem cell transplant—may be utilised as consolidation therapy. By substituting leukemic bone marrow with leukemia-free bone marrow from a healthy individual, this treatment enables a person with leukaemia to restore healthy bone marrow.
High doses of radiation or chemotherapy are used prior to a bone marrow transplant in order to eradicate any leukemia-producing bone marrow. After that, bone marrow from a compatible donor is used to replace the marrow (allogeneic transplant).
Engineering immune cells to fight leukemia
Chimeric antigen receptor (CAR)-T cell therapy is a specialist treatment that involves engineering your body's germ-fighting T cells to attack cancer and then reintroducing them into your body.
Children and young adults may be candidates for CAR-T cell treatment. It could be applied to relapse treatment or consolidation therapy.
Clinical trials
Clinical trials are investigations to evaluate novel cancer therapies as well as novel applications of current treatments. Clinical trials provide you or your kid the opportunity to explore the newest cancer treatment, but the treatment's advantages and disadvantages might not be clear. Talk to your physician about the advantages and disadvantages of clinical trials.
Best Doctors in India
Cost of Acute Lymphocytic Leukemia in India
The cost of treatment for acute lymphocytic leukaemia in Indian patients ranges from $10,200 to $13,600. Patients from other countries will pay between $15,300 and $18,700.
Top Hospitals in India
Indications of Acute Lymphocytic Leukemia:
Acute Lymphocytic Leukaemia Symptoms
Symptoms of acute lymphoblastic leukaemia (ALL) can include:
Fatigue: A persistent state of exhaustion or low energy that makes it difficult to go about daily tasks.
Weakness: A generalised loss of muscle power or strength.
Pale skin: A notably lighter complexion is a hallmark of anaemia.
Frequent Infections: A compromised immune system makes a person more vulnerable to infections.
Fever: An underlying infection or inflammation is frequently linked to fever.
Easy bleeding or bruises: Frequent and inexplicable bleeding or bruises may be signs of blood clotting problems.
Petechie (small red spots on the skin): Petechiae, or tiny red or purple spots on the skin, are caused by bleeding beneath the surface.
Bone pain: Aches or discomfort that come from the bones.
Joint Pain: Joint stiffness, pain, or discomfort.
Swollen Lymph Nodes: Swollen lymph nodes are enlarged lymph nodes that are typically located in the groin, armpit, or neck.
Enlarged liver or spleen: These organs are abnormally enlarged and frequently palpable during a medical examination.
Headaches: Severe or persistent headaches may be a sign of elevated cranial pressure.
Vision changes: Changes in vision could be a sign of neurological involvement or other issues.
Loss of appetite: A less desire to eat, which results in a lower consumption of food.
Weight loss: A gradual, unintentional decrease in body weight.
Difficulty breathing: Breathing difficulties include feeling out of breath or having trouble breathing.
Abdominal pain: Pain or discomfort in the abdomen, presumably brought on by organ enlargement or other issues.
Acute Lymphocytic Leukaemia Diagnosis
A number of medical evaluations and tests are used to diagnose acute lymphocytic leukaemia (ALL) in order to verify the existence of leukaemia cells in the bone marrow and blood. The following steps are commonly included in the diagnostic process:
Medical History and Physical Examination: In addition to asking about the patient's symptoms and medical history, the healthcare professional will do a comprehensive physical examination to look for any indications of leukaemia.
Blood Tests: To determine the amounts of red blood cells, white blood cells, and platelets, a complete blood count (CBC) is performed. Leukaemia cells may be present if there are abnormalities.
Bone Marrow Aspiration and Biopsy: During a bone marrow aspiration and biopsy, a tiny sample of bone tissue and bone marrow is taken from the hip or another major bone. After that, these samples are inspected under a microscope to look for leukaemia cells and evaluate their properties.
Cytogenetic Analysis: To find any anomalies, cytogenetic testing looks at the chromosomes in leukaemia cells. The subtype of ALL can be identified, and treatment choices can be guided by specific chromosomal alterations.
Immunophenotyping: This test helps identify the kind of lymphocytes involved (B-cell or T-cell) and further clarify the diagnosis by examining the particular markers found on the surface of leukaemia cells.
Lumbar Puncture (Spinal Tap): Since leukaemia can occasionally spread to the central nervous system, a lumbar puncture may occasionally be carried out to check for the presence of leukaemia cells in the cerebrospinal fluid.
Risk Factors:
A person may be more likely to develop ALL even if they have one or more risk factors.
Age: Young children experience the highest frequency; older adults experience a second, smaller peak.
Sex: Males are slightly more likely to
Genetic conditions: Risk is increased by Down syndrome and several uncommon genetic syndromes.
The majority of ALL cases are random and not inherited, but there is a very small elevated risk associated with a family history of leukaemia.
Environmental: Rare exposure to specific chemicals or high-dose radiation
Previous cancer treatment: Previous radiation or chemotherapy for a different cancer